Pages that link to "Q35208414"
Jump to navigation
Jump to search
The following pages link to Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity (Q35208414):
Displaying 50 items.
- NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? (Q26746478) (← links)
- Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy (Q26772347) (← links)
- The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer (Q26774678) (← links)
- Newtonian cell interactions shape natural killer cell education (Q26797240) (← links)
- NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma (Q26991949) (← links)
- NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma (Q27001052) (← links)
- NKG2D ligands as therapeutic targets (Q27014888) (← links)
- From mice to humans: developments in cancer immunoediting (Q28088304) (← links)
- The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions (Q28589215) (← links)
- The immune contexture in human tumours: impact on clinical outcome (Q29620667) (← links)
- Altered expression of miR-181a and miR-146a does not change the expression of surface NCRs in human NK cells. (Q30364263) (← links)
- Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids (Q30648415) (← links)
- DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins (Q30716850) (← links)
- NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus (Q33682274) (← links)
- Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade (Q33714165) (← links)
- On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C (Q33803540) (← links)
- Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours (Q33861833) (← links)
- New insights into the role of EMT in tumor immune escape. (Q33869781) (← links)
- mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function. (Q34364808) (← links)
- Balancing natural killer cell activation through paired receptors (Q34465877) (← links)
- CD11b(-)CD27(-) NK cells are associated with the progression of lung carcinoma (Q34658702) (← links)
- NK cells and T cells cooperate during the clinical course of colorectal cancer (Q34933101) (← links)
- Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity (Q35110486) (← links)
- A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis (Q35131244) (← links)
- Cytokines reinstate NK cell-mediated cancer immunosurveillance (Q35140082) (← links)
- Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus (Q35158581) (← links)
- Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy (Q35474102) (← links)
- Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model. (Q35595605) (← links)
- CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis (Q35674757) (← links)
- Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity. (Q35786749) (← links)
- Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art. (Q35799695) (← links)
- Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity (Q35940189) (← links)
- Ionomycin Treatment Renders NK Cells Hyporesponsive (Q35967256) (← links)
- Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer (Q35987354) (← links)
- Tumor microenvironment in NSCLC suppresses NK cells function (Q36038484) (← links)
- Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells (Q36057599) (← links)
- Potential Use of Natural Killer Cell Transfer Therapy in the Perioperative Period to Improve Oncologic Outcomes (Q36245682) (← links)
- Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia (Q36256263) (← links)
- Biological role of NK cells and immunotherapeutic approaches in breast cancer (Q36460884) (← links)
- Natural killer cells in non-hematopoietic malignancies (Q36486204) (← links)
- Lung tumor microenvironment induces specific gene expression signature in intratumoral NK cells (Q36584068) (← links)
- A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis (Q36643655) (← links)
- The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia (Q36772346) (← links)
- Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay. (Q36821232) (← links)
- Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells. (Q36833481) (← links)
- NK cells from malignant pleural effusions are potent antitumor effectors: A clue for adoptive immunotherapy? (Q36845810) (← links)
- Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients. (Q36960012) (← links)
- The immune microenvironment of human tumors: general significance and clinical impact (Q37028764) (← links)
- The immune system and inflammation in breast cancer (Q37033451) (← links)
- VEGFR2 targeted antibody fused with MICA stimulates NKG2D mediated immunosurveillance and exhibits potent anti-tumor activity against breast cancer (Q37086056) (← links)